Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014 Apr 3;106(5):dju063.
doi: 10.1093/jnci/dju063.

Re: Concordance between CYP2D6 genotypes obtained from tumor-derived and germline DNA

Matthew P Goetz  1 , Hiltrud Brauch  2 , Mark J Ratain  2 , Nancy J Cox  2 , Yusuke Nakamura  2 , Richard Weinshilboum  2 , James N Ingle  2
Affiliations
Comment

Re: Concordance between CYP2D6 genotypes obtained from tumor-derived and germline DNA

Matthew P Goetz et al. J Natl Cancer Inst. .
No abstract available

PubMed Disclaimer

Comment in

  • Response.
    Rae JM, Leyland-Jones B, Regan M. Rae JM, et al. J Natl Cancer Inst. 2014 Apr 3;106(5):dju064. doi: 10.1093/jnci/dju064. J Natl Cancer Inst. 2014. PMID: 24700799 No abstract available.
  • Response.
    Berry DA. Berry DA. J Natl Cancer Inst. 2014 Apr 3;106(5):dju065. doi: 10.1093/jnci/dju065. J Natl Cancer Inst. 2014. PMID: 24700800 No abstract available.

Comment on

References

    1. Schroth W, Goetz MP, Hamann U, et al. Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen. JAMA. 2009;302(13):1429–1436. - PMC - PubMed
    1. Regan MM, Leyland-Jones B, Bouzyk M, et al. CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 Trial. J Natl Cancer Inst. 2012;104(6):441–451. - PMC - PubMed
    1. Rae JM, Drury S, Hayes DF, et al. CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients. J Natl Cancer Inst. 2012;104(6):452–460. - PMC - PubMed
    1. Nakamura Y, Ratain MJ, Cox NJ, McLeod HL, Kroetz DL, Flockhart DA. Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial. J Natl Cancer Inst. 2012;104(16):1264; author reply 1266–1268. - PubMed
    1. Stanton V., Jr Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial. J Natl Cancer Inst. 2012;104(16):1265–1266; author reply 1266–1268. - PubMed